408 related articles for article (PubMed ID: 15240610)
1. Augmentation of growth hormone secretion after testosterone treatment in boys with constitutional delay of growth and adolescence: evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone.
Racine MS; Symons KV; Foster CM; Barkan AL
J Clin Endocrinol Metab; 2004 Jul; 89(7):3326-31. PubMed ID: 15240610
[TBL] [Abstract][Full Text] [Related]
2. The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion.
Eakman GD; Dallas JS; Ponder SW; Keenan BS
J Clin Endocrinol Metab; 1996 Mar; 81(3):1217-23. PubMed ID: 8772602
[TBL] [Abstract][Full Text] [Related]
3. Accelerated escape from GH autonegative feedback in midpuberty in males: evidence for time-delimited GH-induced somatostatinergic outflow in adolescent boys.
Richmond E; Rogol AD; Basdemir D; Veldhuis OL; Clarke W; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2002 Aug; 87(8):3837-44. PubMed ID: 12161519
[TBL] [Abstract][Full Text] [Related]
4. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone.
Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504
[TBL] [Abstract][Full Text] [Related]
5. Nocturnal naloxone fails to reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion in pubertal boys.
Kletter GB; Foster CM; Brown MB; Beitins IZ; Marshall JC; Kelch RP
J Clin Endocrinol Metab; 1994 Oct; 79(4):1147-51. PubMed ID: 7962287
[TBL] [Abstract][Full Text] [Related]
6. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
Veldhuis JD; Evans WS; Bowers CY
J Clin Endocrinol Metab; 2003 Nov; 88(11):5484-9. PubMed ID: 14602794
[TBL] [Abstract][Full Text] [Related]
7. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
Cemeroglu AP; Barkan AL; Kletter GB; Beitins IZ; Foster CM
J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.
Jaffe CA; Turgeon DK; Friberg RD; Watkins PB; Barkan AL
J Clin Endocrinol Metab; 1995 Nov; 80(11):3321-6. PubMed ID: 7593445
[TBL] [Abstract][Full Text] [Related]
9. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
[TBL] [Abstract][Full Text] [Related]
10. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
11. A persistent pattern of varying pituitary responsivity to exogenous growth hormone (GH)-releasing hormone in GH-deficient children: evidence supporting periodic somatostatin secretion.
Martha PM; Blizzard RM; McDonald JA; Thorner MO; Rogol AD
J Clin Endocrinol Metab; 1988 Sep; 67(3):449-54. PubMed ID: 2900843
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
[TBL] [Abstract][Full Text] [Related]
13. Semiquantification of hypothalamic GH-releasing hormone output in women: evidence for sexual dimorphism in the mechanism of the somatopause.
Orrego JJ; Russell-Aulet M; Demott-Friberg R; Barkan AL
J Clin Endocrinol Metab; 2001 Nov; 86(11):5485-90. PubMed ID: 11701726
[TBL] [Abstract][Full Text] [Related]
14. Physiological testosterone replenishment in healthy elderly men does not normalize pituitary growth hormone output: evidence against the connection between senile hypogonadism and somatopause.
Orrego JJ; Dimaraki E; Symons K; Barkan AL
J Clin Endocrinol Metab; 2004 Jul; 89(7):3255-60. PubMed ID: 15240600
[TBL] [Abstract][Full Text] [Related]
15. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
Veldhuis JD; Evans WS; Bowers CY
J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
[TBL] [Abstract][Full Text] [Related]
16. Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone.
Giustina A; Scalvini T; Tassi C; Desenzani P; Poiesi C; Wehrenberg WB; Rogol AD; Veldhuis JD
J Clin Endocrinol Metab; 1997 Apr; 82(4):1210-9. PubMed ID: 9100598
[TBL] [Abstract][Full Text] [Related]
17. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
[TBL] [Abstract][Full Text] [Related]
18. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
[TBL] [Abstract][Full Text] [Related]
19. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys.
Wu FC; Brown DC; Butler GE; Stirling HF; Kelnar CJ
J Clin Endocrinol Metab; 1993 Jan; 76(1):26-31. PubMed ID: 8421096
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men.
Koutkia P; Canavan B; Breu J; Johnson ML; Grinspoon SK
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E506-12. PubMed ID: 15138154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
